Hem/Onc Roundup: Lung Cancer Screenings Decline, Insurance Status Linked to Myeloma Survival, and More

Study: Lung Cancer Screening Amid the COVID-19 Pandemic

A review found a decline in lung cancer screening, but an overall rise in malignancies since the COVID-19 pandemic. In this study, researchers compared monthly visits for low-dose computed tomography screening for lung cancer during the three months of COVID-19 restrictions. The article appeared in Journal of the American College of Surgeons. 

Advertisement

https://www.docwirenews.com/hematology-oncology/study-lung-cancer-screening-amid-the-covid-19-pandemic/

–

Vitamin D Deficiency Linked to Pancreatic Cancer Survival

Vitamin D deficiency prior to cancer treatment is associated with increased inflammation and shorter overall survival in patients with pancreatic cancer. Across all disease stages, vitamin D-deficient patients had the highest median levels of inflammatory biomarkers compared with the other groups. Patients with stage I or II disease and vitamin D deficiency also had a higher hazard ratio for mortality.

https://www.docwirenews.com/docwire-pick/vitamin-d-deficiency-linked-to-pancreatic-cancer-survival/

–

Insurance Status Linked to Survival for Patients with Multiple Myeloma